MP092APABETALONE, A BROMODOMAIN AND EXTRATERMINAL PROTEIN INHIBITOR, DECREASES KEY FACTORS IN VASCULAR CALCIFICATION IN VITRO AND IN CLINICAL TRIALS

Authors :: Christopher Halliday
Laura Tsujikawa
Brooke Rakai
Jan Johansson
Ravi Jahagirdar
Richard A. Robson
Ewelina Kulikowski
Sylwia Wasiak
Dean Gilham
Norman C.W. Wong
Michael O. Sweeney
Kam Kalantar-Zadeh
Source :: Nephrology Dialysis Transplantation. 32:iii459-iii459
Publication Year :: 2017
Publisher :: Oxford University Press (OUP), 2017.

Subjects :: Clinical trial
Transplantation
Key factors
Nephrology
business.industry
Proteinase inhibitor
Immunology
Medicine
Pharmacology
business
Vascular calcification
In vitro
Bromodomain

Tools